Documents & Downloads

(R)-tetraMe-Tetraxetan

BFC

(R)-tetraMe-Tetraxetan is a bifunctional chelator (BFC) and a macrocyclic derivative of DOTA, designed for tumor pre-targeting applications. This compound facilitates the selective conjugation of peptides and radionuclides, enhancing the efficiency of targeted imaging and therapy. Its unique structure allows for improved binding characteristics, making it a valuable tool in cancer research and the development of radiopharmaceuticals.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	148408-89-3
Applications	BFC
Formula	C₂₀H₃₆N₄O₈
Molecular Weight	460.52
Synonyms	(R)-tetraMe-DOTA
SMILES	OC([C@H](N1CCN(CCN(CCN(CC1)[C@H](C)C(O)=O)[C@H](C)C(O)=O)[C@H](C)C(O)=O)C)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.